Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Yaron Weber is an analyst at TD Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/20/2025
Buy Now | Get Alert | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
05/20/2025 | ZYME | Buy Now | Zymeworks | $12.43 | — | Yaron Weber37% | — | Initiates | → Buy | Get Alert |
10/21/2024 | AMGN | Buy Now | Amgen | $275.01 | 39.27% | Yaron Weber37% | $381 → $383 | Maintains | Buy | Get Alert |
08/07/2024 | AMGN | Buy Now | Amgen | $275.01 | 38.54% | Yaron Weber37% | $360 → $381 | Maintains | Buy | Get Alert |
04/17/2024 | AMGN | Buy Now | Amgen | $275.01 | 30.9% | Yaron Weber37% | $370 → $360 | Maintains | Buy | Get Alert |
02/28/2023 | BGNE | Buy Now | BeiGene | — | — | Yaron Weber37% | $213 → $262 | Maintains | Outperform | Get Alert |
02/01/2023 | AMGN | Buy Now | Amgen | $275.01 | 5.09% | Yaron Weber37% | $307 → $289 | Maintains | Outperform | Get Alert |
03/08/2021 | NUVB | Buy Now | Nuvation Bio | $2.17 | — | Yaron Weber37% | — | Initiates | → Outperform | Get Alert |
02/08/2021 | REGN | Buy Now | Regeneron Pharmaceuticals | $614.79 | -8.1% | Yaron Weber37% | $684 → $565 | Maintains | Outperform | Get Alert |
12/20/2019 | AMGN | Buy Now | Amgen | $275.01 | 0.72% | Yaron Weber37% | $253 → $277 | Maintains | Outperform | Get Alert |